Colgate-Palmolive (NYSE:CL) Shares Sold by Golden State Equity Partners

Golden State Equity Partners lowered its stake in Colgate-Palmolive (NYSE:CL) by 12.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,514 shares of the company’s stock after selling 361 shares during the quarter. Golden State Equity Partners’ holdings in Colgate-Palmolive were worth $200,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. OFI Invest Asset Management acquired a new position in Colgate-Palmolive in the 3rd quarter valued at approximately $25,000. Avion Wealth increased its stake in shares of Colgate-Palmolive by 78.1% during the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after purchasing an additional 175 shares during the last quarter. McGlone Suttner Wealth Management Inc. bought a new stake in Colgate-Palmolive in the fourth quarter worth $34,000. Kayne Anderson Rudnick Investment Management LLC raised its holdings in Colgate-Palmolive by 142.0% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock valued at $35,000 after buying an additional 291 shares in the last quarter. Finally, West Branch Capital LLC boosted its stake in shares of Colgate-Palmolive by 24.0% during the 4th quarter. West Branch Capital LLC now owns 682 shares of the company’s stock worth $54,000 after acquiring an additional 132 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CEO Noel R. Wallace sold 50,000 shares of Colgate-Palmolive stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the sale, the chief executive officer now owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, insider Jennifer Daniels sold 61,633 shares of the business’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $83.93, for a total transaction of $5,172,857.69. Following the completion of the sale, the insider now owns 57,948 shares in the company, valued at $4,863,575.64. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Noel R. Wallace sold 50,000 shares of Colgate-Palmolive stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the sale, the chief executive officer now directly owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The disclosure for this sale can be found here. In the last ninety days, insiders sold 232,371 shares of company stock valued at $19,505,099. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of CL stock opened at $91.01 on Monday. The firm’s 50 day moving average price is $87.66 and its two-hundred day moving average price is $81.63. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11. The stock has a market cap of $74.81 billion, a PE ratio of 28.80, a PEG ratio of 3.42 and a beta of 0.42. Colgate-Palmolive has a 52-week low of $67.62 and a 52-week high of $92.25.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, beating analysts’ consensus estimates of $0.82 by $0.04. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The business had revenue of $5.07 billion for the quarter, compared to the consensus estimate of $4.96 billion. During the same period last year, the company posted $0.73 EPS. Colgate-Palmolive’s revenue for the quarter was up 6.2% on a year-over-year basis. As a group, analysts forecast that Colgate-Palmolive will post 3.5 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be issued a dividend of $0.50 per share. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 annualized dividend and a yield of 2.20%. The ex-dividend date of this dividend is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is 63.29%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. TheStreet upgraded shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a report on Friday, January 26th. JPMorgan Chase & Co. increased their price objective on Colgate-Palmolive from $88.00 to $90.00 and gave the company an “overweight” rating in a research report on Thursday, January 18th. StockNews.com cut shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, February 20th. Evercore ISI upped their price objective on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a research report on Monday, April 8th. Finally, The Goldman Sachs Group began coverage on Colgate-Palmolive in a research note on Friday, March 1st. They set a “buy” rating and a $93.00 price target on the stock. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $89.50.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.